News | August 04, 2008

SpectraCell Offers Aspirin Response Testing

August 5, 2008 - SpectraCell Laboratories now offers Aspirin Response Testing (ART), designed to measure a person's response to low-dose aspirin therapy, which is routinely prescribed to millions of Americans for cardiovascular disease prevention.
Recent research has shown that the effects of aspirin in reducing blood (platelet) "stickiness" will vary considerably from patient to patient. Studies show that individuals who do not respond to aspirin (in reducing platelet stickiness) are more than three times more likely to die from heart disease than those that respond well to aspirin. ART will reportedly tell clinicians if aspirin therapy is working, while it also helps them determine the appropriate dosage of aspirin for each patient, allowing a doctor to tailor their recommendations to the individual.
Platelets are small blood cells that stick together to form blood clots and control bleeding. They produce a chemical called thromboxane to attract other platelets and increase their stickiness. Aspirin works by inhibiting the production of thromboxane by platelets, therefore reducing their stickiness and limiting the size of clots.
ART measures the level of thromboxane production in apparently healthy individuals. The enzyme-linked immunoassay (ELISA) measures the levels of 11-Dehydro Thromboxane B2 (11dhTxB2) in human urine. It reflects in vivo production of thromboxane A2, which is the target of aspirin therapy. Clinical studies such as the large HOPE (Heart Outcomes Prevention Evaluation) study have shown that elevated levels of 11dhTxB2 correlate to increased cardiovascular risk.
There are several reasons why a patient may not respond well to aspirin. It may be as simple as a patient taking a dose too low to effectively inhibit thromboxane A2 production. Platelets can also be activated by pathways that are not blocked by aspirin so other anti-thrombotic therapies may benefit patients that are resistant to aspirin for this reason.
Standard platelet function tests require freshly drawn blood and must be evaluated within four hours. However, since ART uses a random urine sample, it is not subject to variables associated with blood sampling. In addition, aspirin response is highly assay-specific, meaning that a patient may not test positive for aspirin resistance with tests that stimulate platelet aggregation in vitro via other, less specific pathways. ART is done in vivo and specifically measures stable thromboxane metabolites. The final results are reported in picograms of 11dhTxB2 per milligram of creatine to standardize results to urine concentration.
For more information: www.spectracell.com

Related Content

Healcerion Receives FDA Approval for Sonon 300L Handheld Ultrasound Device
Technology | Ultrasound Imaging | July 09, 2018
South Korea-based Healcerion launched the Sonon 300L wireless handheld ultrasound device to the U.S. market following U...
Esaote Change of Ownership Completed
News | Ultrasound Imaging | April 30, 2018
The acquisition of biomedical equipment company Esaote SpA’s share capital was completed on April 19, the company...
Philips Integrates Reacts Tele-Ultrasound Platform on Lumify Portable Systems

Image courtesy of Philips Healthcare

News | Ultrasound Imaging | March 30, 2018
Philips in partnership with Innovative Imaging Technologies (IIT) announced an industry-first integrated tele-...
Toshiba Medical Rolls Out Interactive Learning Tools for Ultrasound and Vascular Training
News | Ultrasound Imaging | December 04, 2017
Toshiba Medical, a Canon Group company, introduced new educational tools and interactive learning resources to help...
Toshiba Medical's Portable Ultrasound Used in Second Pediatric Mission in Tanzania
News | Ultrasound Imaging | October 05, 2017
October 5, 2017 — To provide lifesaving surgical care for sick children in one of the most underserved countries, 13
Clarius Wireless Ultrasound Scanners Now Available With Advanced Features
News | Ultrasound Imaging | August 09, 2017
Clarius Mobile Health has released advanced features and options for its wireless handheld ultrasound scanner for...
Oregon Tech Partners with Mindray for High-Tech Ultrasound Education
News | Ultrasound Imaging | August 04, 2017
To better prepare its ultrasound students to compete and thrive in the evolving healthcare environment, Oregon...
News | Ultrasound Imaging | March 28, 2017
Young rabbits exposed to ultrasound during fetal development had weaker thighbones than unexposed rabbits, according to...
ultrasound systems market, $5 billion, 2023, GlobalData report
News | Ultrasound Imaging | January 25, 2017
The ultrasound systems space, which covers 39 major markets, is set to rise steadily from $4.2 billion in 2016 to $5...
GE Healthcare, Vscan Extend, app-based ultrasound, dual-probe, RSNA 2017
Technology | Ultrasound Imaging | January 12, 2017
GE Healthcare unveiled its new generation of pocket-sized, dual-probe ultrasound, the Vscan Extend. From the hospital...
Overlay Init